Ethic Inc. Boston Scientific Corp Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Ethic Inc. holds 268,848 shares of BSX stock, worth $26.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

268,848

Previous 241,929 11.13%

Holding current value

$26.7 Million

Previous $21.6 Million 25.51%

% of portfolio

0.57%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$89.38 - $106.18 $2.41 Million - $2.86 Million	26,919 Added 11.13%	268,848 $27.1 Million
Q4 2024 Feb 14, 2025	BUY	$83.62 - $91.5 $3.93 Million - $4.3 Million	46,946 Added 24.08%	241,929 $21.6 Million
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $1.57 Million - $1.8 Million	-21,479 Reduced 9.92%	194,983 $16.3 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $1.45 Million - $1.67 Million	21,479 Added 11.02%	216,462 $16.7 Million
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $1.09 Million - $1.3 Million	19,001 Added 10.8%	194,983 $13.4 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $517,821 - $615,445	10,646 Added 6.44%	175,982 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $625,869 - $681,859	12,470 Added 8.16%	165,336 $8.73 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $310,302 - $341,008	6,241 Added 4.26%	152,866 $8.27 Million
Q1 2023 May 12, 2023	BUY	$45.09 - $50.03 $796,063 - $883,279	17,655 Added 13.69%	146,625 $7.34 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $517,523 - $617,732	13,082 Added 11.29%	128,970 $5.97 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $695,984 - $2.08 Million	18,959 Added 19.56%	115,888 $4.49 Million
Q2 2022 Aug 10, 2022	BUY	$35.24 - $47.1 $644,222 - $861,035	18,281 Added 23.24%	96,929 $3.61 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $489,941 - $540,252	11,979 Added 17.97%	78,648 $3.48 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $262,492 - $309,378	6,895 Added 11.54%	66,669 $2.83 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $321,470 - $357,726	7,797 Added 15.0%	59,774 $2.59 Million
Q2 2021 Aug 10, 2021	BUY	$38.58 - $44.24 $696,677 - $798,885	18,058 Added 53.24%	51,977 $2.22 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $518,222 - $582,871	14,693 Added 76.42%	33,919 $1.31 Million
Q4 2020 Feb 10, 2021	SELL	$33.15 - $41.97 $65,603 - $83,058	-1,979 Reduced 9.33%	19,226 $691,000
Q3 2020 Oct 27, 2020	BUY	$34.44 - $42.23 $497,623 - $610,181	14,449 Added 213.87%	21,205 $810,000
Q2 2020 Aug 12, 2020	BUY	$30.19 - $39.11 $39,579 - $51,273	1,311 Added 24.08%	6,756 $237,000
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $206,202 - $247,039	5,445 New	5,445 $246,000

Others Institutions Holding BSX

# of Institutions

1,832

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $142B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account